title: Bortezomib.
authors.affiliation: Decision Resources International, London, UK. aparamore@decisionresources.co.uk
authors.forename: Andrew
authors.initials: A
authors.lastname: Paramore
authors.forename: Simon
authors.initials: S
authors.lastname: Frantz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib